Tiziana Life Sciences PLC - London-based therapeutics for oncology, inflammation and infectious diseases - Pretax loss in 2020 widens to GBP22.1 million from GBP7.8 million. Widened loss partly down to company paying GBP10.3 million in realisation bonus, compared to no such costs in 2019.
Current stock price: 71.99 pence, down 5.2% on Tuesday
Year-to-date change: down 21%
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.